Clinical trial · Interventional
Use of Plasma Rich in Growth Factors (PRGF) in Pilonidal Sinus Excision
Application of PRGF (Plasma Rich in Growth Factors) to Reduce the Healing Time After Pilonidal Sinus Excision. A Randomized 5-years Prospective Controlled Trial.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The use of plasma rich in growth factors in wound excision pilonidal sinus could improve the healing process of the wound, when compared with the usual technique of daily local healing. The investigators propose the objective of evaluating the efficacy of intra- and postoperative application of plasma rich in growth factors, to reduce healing time and complications, arising from its removal, compared to the standard surgical treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pilonidal Sinus | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| sinus pilonidal excision and standard cares | Procedure | — | UNRESOLVED |
| sinus pilonidal excision+ PRGF | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- control group
- description
- sinus pilonidal excision and standard cares
- interventionNames
- Procedure: sinus pilonidal excision and standard cares
- type
- EXPERIMENTAL
- label
- PRGF group
- description
- sinus pilonidal excision+ PRGF
- interventionNames
- Procedure: sinus pilonidal excision+ PRGF
Primary outcomes (1)
- measure
- healing time(days) of pilonidal sinus wound excision
- timeFrame
- 6 months
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 13 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Patients among 13 and 65 years old * Possibility of observation during the follow-up period * Patients who have read and signed informed consent Exclusion Criteria: * Abscessed pilonidal sinus * Recurrent pilonidal sinus * Patients treated with immunosuppressive drugs or anticoagulants
References
Publications (0)
Data not yet available